{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T19:59:08Z","timestamp":1772135948507,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T00:00:00Z","timestamp":1585872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australian Postgraduate Award"},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1022150"],"award-info":[{"award-number":["1022150"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001111","name":"Cancer Australia","doi-asserted-by":"publisher","award":["1105828"],"award-info":[{"award-number":["1105828"]}],"id":[{"id":"10.13039\/501100001111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004267","name":"Royal Adelaide Hospital","doi-asserted-by":"publisher","award":["Near Miss Funding"],"award-info":[{"award-number":["Near Miss Funding"]}],"id":[{"id":"10.13039\/501100004267","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumour vasculature supports the growth and progression of solid cancers with both angiogenesis (endothelial cell proliferation) and vasculogenic mimicry (VM, the formation of vascular structures by cancer cells themselves) predictors of poor patient outcomes. Increased circulating platelet counts also predict poor outcome for cancer patients but the influence of platelets on tumour vasculature is incompletely understood. Herein, we show with\n                    <jats:italic>in vitro<\/jats:italic>\n                    assays that platelets did not influence angiogenesis but did actively inhibit VM formation by cancer cell lines. Both platelet sized beads and the releasates from platelets were partially effective at inhibiting VM formation suggesting that direct contact maximises the effect. Platelets also promoted cancer cell invasion\n                    <jats:italic>in vitro<\/jats:italic>\n                    . B16F10 melanomas in\n                    <jats:italic>Bcl-x<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>Plt20\/Plt20<\/jats:italic>\n                    <\/jats:sup>\n                    thrombocytopenic mice showed a higher content of VM than their wildtype counterparts while angiogenesis did not differ. In a xenograft mouse model of breast cancer with low-dose aspirin to inactivate the platelets, the burden of MDA-MB-231-LM2 breast cancer cells was reduced and the gene expression profile of the cancer cells was altered; but no effect on tumour vasculature was observed. Taken together, this study provides new insights into the action of platelets on VM formation and their involvement in cancer progression.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-62648-x","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T06:06:32Z","timestamp":1585893992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Platelets disrupt vasculogenic mimicry by cancer cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Carmela","family":"Martini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5006-1627","authenticated-orcid":false,"given":"Stephanie R.","family":"Hyslop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaelia P.","family":"Cockshell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6478-5204","authenticated-orcid":false,"given":"Emma C.","family":"Josefsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9875-967X","authenticated-orcid":false,"given":"Claudine S.","family":"Bonder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,3]]},"reference":[{"key":"62648_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archinte.1964.03860100079008","volume":"114","author":"J Levin","year":"1964","unstructured":"Levin, J. & Conley, C. L. Thrombocytosis Associated with Malignant Disease. Arch. Intern. Med. 114, 497\u2013500 (1964).","journal-title":"Arch. Intern. Med."},{"key":"62648_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1183\/09031936.96.09091826","volume":"9","author":"LM Pedersen","year":"1996","unstructured":"Pedersen, L. M. & Milman, N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur. Respir. J. 9, 1826\u20131830 (1996).","journal-title":"Eur. Respir. J."},{"key":"62648_CR3","doi-asserted-by":"publisher","first-page":"289563","DOI":"10.1155\/2013\/289563","volume":"2013","author":"A Stravodimou","year":"2013","unstructured":"Stravodimou, A. & Voutsadakis, I. A. Pretreatment thrombocytosis as a prognostic factor in metastatic breast cancer. Int. J. Breast Cancer 2013, 289563, https:\/\/doi.org\/10.1155\/2013\/289563 (2013).","journal-title":"Int. J. Breast Cancer"},{"key":"62648_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.trecan.2017.01.006","volume":"3","author":"SR Hyslop","year":"2017","unstructured":"Hyslop, S. R. & Josefsson, E. C. Undercover Agents: Targeting Tumours with Modified Platelets. Trends Cancer 3, 235\u2013246, https:\/\/doi.org\/10.1016\/j.trecan.2017.01.006 (2017).","journal-title":"Trends Cancer"},{"key":"62648_CR5","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.271.10.5892","volume":"271","author":"B Felding-Habermann","year":"1996","unstructured":"Felding-Habermann, B., Habermann, R., Saldivar, E. & Ruggeri, Z. M. Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow. J. Biol. Chem. 271, 5892\u20135900 (1996).","journal-title":"J. Biol. Chem."},{"key":"62648_CR6","first-page":"1295","volume":"59","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt, B., Hafner, M., Echtenacher, B. & Mannel, D. N. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res. 59, 1295\u20131300 (1999).","journal-title":"Cancer Res."},{"key":"62648_CR7","doi-asserted-by":"publisher","first-page":"9482","DOI":"10.1073\/pnas.1633689100","volume":"100","author":"M Rolli","year":"2003","unstructured":"Rolli, M., Fransvea, E., Pilch, J., Saven, A. & Felding-Habermann, B. Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 9482\u20139487, https:\/\/doi.org\/10.1073\/pnas.1633689100 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62648_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina, E. I. & Quigley, J. P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25, 9\u201334, https:\/\/doi.org\/10.1007\/s10555-006-7886-9 (2006).","journal-title":"Cancer Metastasis Rev."},{"key":"62648_CR9","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(98)05095-8","volume":"352","author":"HM Pinedo","year":"1998","unstructured":"Pinedo, H. M., Verheul, H. M., D\u2019Amato, R. J. & Folkman, J. Involvement of platelets in tumour angiogenesis? Lancet 352, 1775\u20131777 (1998).","journal-title":"Lancet"},{"key":"62648_CR10","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1073\/pnas.94.2.663","volume":"94","author":"R Mohle","year":"1997","unstructured":"Mohle, R., Green, D., Moore, M. A., Nachman, R. L. & Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl Acad. Sci. USA 94, 663\u2013668 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62648_CR11","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1160\/TH16-08-0615","volume":"117","author":"C Ay","year":"2017","unstructured":"Ay, C., Pabinger, I. & Cohen, A. T. Cancer-associated venous thromboembolism: Burden, mechanisms, and management. Thromb. Haemost. 117, 219\u2013230, https:\/\/doi.org\/10.1160\/TH16-08-0615 (2017).","journal-title":"Thromb. Haemost."},{"key":"62648_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma, M., Biziato, D. & Petrova, T. V. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17, 457\u2013474, https:\/\/doi.org\/10.1038\/nrc.2017.51 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"62648_CR13","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182\u20131186, https:\/\/doi.org\/10.1056\/NEJM197111182852108 (1971).","journal-title":"N. Engl. J. Med."},{"key":"62648_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc3004","volume":"11","author":"LJ Gay","year":"2011","unstructured":"Gay, L. J. & Felding-Habermann, B. Contribution of platelets to tumour metastasis. Nat. Rev. Cancer 11, 123\u2013134, https:\/\/doi.org\/10.1038\/nrc3004 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"62648_CR15","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1182\/blood-2010-12-327007","volume":"117","author":"M Chatterjee","year":"2011","unstructured":"Chatterjee, M. et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli. Blood 117, 3907\u20133911, https:\/\/doi.org\/10.1182\/blood-2010-12-327007 (2011).","journal-title":"Blood"},{"key":"62648_CR16","doi-asserted-by":"publisher","first-page":"6851","DOI":"10.1158\/0008-5472.CAN-08-0718","volume":"68","author":"B Ho-Tin-Noe","year":"2008","unstructured":"Ho-Tin-Noe, B., Goerge, T., Cifuni, S. M., Duerschmied, D. & Wagner, D. D. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 68, 6851\u20136858, https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0718 (2008).","journal-title":"Cancer Res."},{"key":"62648_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/bjc.2017.214","volume":"117","author":"L Jiang","year":"2017","unstructured":"Jiang, L. et al. Platelet releasate promotes breast cancer growth and angiogenesis via VEGF-integrin cooperative signalling. Br. J. Cancer 117, 695\u2013703, https:\/\/doi.org\/10.1038\/bjc.2017.214 (2017).","journal-title":"Br. J. Cancer"},{"key":"62648_CR18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1053\/j.seminoncol.2014.04.007","volume":"41","author":"M Yan","year":"2014","unstructured":"Yan, M., Lesyk, G., Radziwon-Balicka, A. & Jurasz, P. Pharmacological regulation of platelet factors that influence tumor angiogenesis. Semin. Oncol. 41, 370\u2013377, https:\/\/doi.org\/10.1053\/j.seminoncol.2014.04.007 (2014).","journal-title":"Semin. Oncol."},{"key":"62648_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane, J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. N. Biol. 231, 232\u2013235 (1971).","journal-title":"Nat. N. Biol."},{"key":"62648_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrclinonc.2012.137","volume":"9","author":"WK Chia","year":"2012","unstructured":"Chia, W. K., Ali, R. & Toh, H. C. Aspirin as adjuvant therapy for colorectal cancer\u2013reinterpreting paradigms. Nat. Rev. Clin. Oncol. 9, 561\u2013570, https:\/\/doi.org\/10.1038\/nrclinonc.2012.137 (2012).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"62648_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/M16-0577","volume":"164","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo, K. & Force, U. S. P. S. T. Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 164, 836\u2013845, https:\/\/doi.org\/10.7326\/M16-0577 (2016).","journal-title":"Ann. Intern. Med."},{"key":"62648_CR22","first-page":"1366","volume":"26","author":"FJ Blanco","year":"1999","unstructured":"Blanco, F. J., Guitian, R., Moreno, J., de Toro, F. J. & Galdo, F. Effect of antiinflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J. Rheumatol. 26, 1366\u20131373 (1999).","journal-title":"J. Rheumatol."},{"key":"62648_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2016.08.021","volume":"11","author":"D Voora","year":"2016","unstructured":"Voora, D. et al. Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer. EBioMedicine 11, 157\u2013164, https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.021 (2016).","journal-title":"EBioMedicine"},{"key":"62648_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/bjc.2014.271","volume":"111","author":"L Alfonso","year":"2014","unstructured":"Alfonso, L., Ai, G., Spitale, R. C. & Bhat, G. J. Molecular targets of aspirin and cancer prevention. Br. J. Cancer 111, 61\u201367, https:\/\/doi.org\/10.1038\/bjc.2014.271 (2014).","journal-title":"Br. J. Cancer"},{"key":"62648_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","volume":"52","author":"R Hanif","year":"1996","unstructured":"Hanif, R. et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52, 237\u2013245 (1996).","journal-title":"Biochem. Pharmacol."},{"key":"62648_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","volume":"191","author":"M Dovizio","year":"2013","unstructured":"Dovizio, M., Bruno, A., Tacconelli, S. & Patrignani, P. Mode of action of aspirin as a chemopreventive agent. Recent. Results Cancer Res. 191, 39\u201365, https:\/\/doi.org\/10.1007\/978-3-642-30331-9_3 (2013).","journal-title":"Recent. Results Cancer Res."},{"key":"62648_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/bph.12250","volume":"170","author":"J Etulain","year":"2013","unstructured":"Etulain, J., Fondevila, C., Negrotto, S. & Schattner, M. Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin. Br. J. Pharmacol. 170, 255\u2013265, https:\/\/doi.org\/10.1111\/bph.12250 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"62648_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1124\/mol.105.011825","volume":"68","author":"M Abdelrahim","year":"2005","unstructured":"Abdelrahim, M. & Safe, S. Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol. Pharmacol. 68, 317\u2013329, https:\/\/doi.org\/10.1124\/mol.105.011825 (2005).","journal-title":"Mol. Pharmacol."},{"key":"62648_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc1092","volume":"3","author":"MJ Hendrix","year":"2003","unstructured":"Hendrix, M. J., Seftor, E. A., Hess, A. R. & Seftor, R. E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3, 411\u2013421, https:\/\/doi.org\/10.1038\/nrc1092 (2003).","journal-title":"Nat. Rev. Cancer"},{"key":"62648_CR30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/s0002-9440(10)65173-5","volume":"155","author":"AJ Maniotis","year":"1999","unstructured":"Maniotis, A. J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155, 739\u2013752, https:\/\/doi.org\/10.1016\/s0002-9440(10)65173-5 (1999).","journal-title":"Am. J. Pathol."},{"key":"62648_CR31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10456-016-9500-2","volume":"19","author":"JP Yang","year":"2016","unstructured":"Yang, J. P. et al. Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis. Angiogenesis 19, 191\u2013200, https:\/\/doi.org\/10.1007\/s10456-016-9500-2 (2016).","journal-title":"Angiogenesis"},{"key":"62648_CR32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/jcb.21855","volume":"105","author":"ZN Demou","year":"2008","unstructured":"Demou, Z. N. & Hendrix, M. J. Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J. Cell Biochem. 105, 562\u2013573, https:\/\/doi.org\/10.1002\/jcb.21855 (2008).","journal-title":"J. Cell Biochem."},{"key":"62648_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6200","volume":"5","author":"JM Dunleavey","year":"2014","unstructured":"Dunleavey, J. M. et al. Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nat. Commun. 5, 5200, https:\/\/doi.org\/10.1038\/ncomms6200 (2014).","journal-title":"Nat. Commun."},{"key":"62648_CR34","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2008.01.080","volume":"368","author":"F Hillen","year":"2008","unstructured":"Hillen, F. et al. A transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors. Biochem. Biophys. Res. Commun. 368, 364\u2013367, https:\/\/doi.org\/10.1016\/j.bbrc.2008.01.080 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"62648_CR35","first-page":"5381","volume":"63","author":"W Ruf","year":"2003","unstructured":"Ruf, W. et al. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res. 63, 5381\u20135389 (2003).","journal-title":"Cancer Res."},{"key":"62648_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/bcr585","volume":"5","author":"K Shirakawa","year":"2003","unstructured":"Shirakawa, K. et al. Inflammatory breast cancer: vasculogenic mimicry and its hemodynamics of an inflammatory breast cancer xenograft model. Breast Cancer Res. 5, 136\u2013139, https:\/\/doi.org\/10.1186\/bcr585 (2003).","journal-title":"Breast Cancer Res."},{"key":"62648_CR37","doi-asserted-by":"publisher","first-page":"e0144081","DOI":"10.1371\/journal.pone.0144081","volume":"10","author":"DA de Souza Junior","year":"2015","unstructured":"de Souza Junior, D. A., Borges, A. C., Santana, A. C., Oliver, C. & Jamur, M. C. Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors. PLoS One 10, e0144081, https:\/\/doi.org\/10.1371\/journal.pone.0144081 (2015).","journal-title":"PLoS One"},{"key":"62648_CR38","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/sj.bjp.0702191","volume":"125","author":"E Pipili-Synetos","year":"1998","unstructured":"Pipili-Synetos, E., Papadimitriou, E. & Maragoudakis, M. E. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br. J. Pharmacol. 125, 1252\u20131257, https:\/\/doi.org\/10.1038\/sj.bjp.0702191 (1998).","journal-title":"Br. J. Pharmacol."},{"key":"62648_CR39","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/bjc.1998.158","volume":"77","author":"RE Banks","year":"1998","unstructured":"Banks, R. E. et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer 77, 956\u2013964 (1998).","journal-title":"Br. J. Cancer"},{"key":"62648_CR40","first-page":"541","volume":"74","author":"M Zucchella","year":"1989","unstructured":"Zucchella, M. et al. Human tumor cells cultured \u201cin vitro\u201d activate platelet function by producing ADP or thrombin. Haematologica 74, 541\u2013545 (1989).","journal-title":"Haematologica"},{"key":"62648_CR41","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason, K. D. et al. Programmed anuclear cell death delimits platelet life span. Cell 128, 1173\u20131186, https:\/\/doi.org\/10.1016\/j.cell.2007.01.037 (2007).","journal-title":"Cell"},{"key":"62648_CR42","doi-asserted-by":"publisher","first-page":"Unit 20 21","DOI":"10.1002\/0471142735.im2001s39","volume":"Chapter 20","author":"WW Overwijk","year":"2001","unstructured":"Overwijk, W. W. & Restifo, N. P. B16 as a mouse model for human melanoma. Curr. Protoc. Immunol. Chapter 20, Unit 20 21, https:\/\/doi.org\/10.1002\/0471142735.im2001s39 (2001).","journal-title":"Curr. Protoc. Immunol."},{"key":"62648_CR43","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1172\/JCI121985","volume":"129","author":"S Lucotti","year":"2019","unstructured":"Lucotti, S. et al. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1\/thromboxane A2. J. Clin. Invest. 129, 1845\u20131862, https:\/\/doi.org\/10.1172\/JCI121985 (2019).","journal-title":"J. Clin. Invest."},{"key":"62648_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature03799","volume":"436","author":"AJ Minn","year":"2005","unstructured":"Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518\u2013524, https:\/\/doi.org\/10.1038\/nature03799 (2005).","journal-title":"Nature"},{"key":"62648_CR45","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1158\/0008-5472.CAN-11-4010","volume":"72","author":"LA Coupland","year":"2012","unstructured":"Coupland, L. A., Chong, B. H. & Parish, C. R. Platelets and P-selectin control tumor cell metastasis in an organ-specific manner and independently of NK cells. Cancer Res. 72, 4662\u20134671, https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4010 (2012).","journal-title":"Cancer Res."},{"key":"62648_CR46","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1016\/j.jacc.2013.05.073","volume":"62","author":"D Voora","year":"2013","unstructured":"Voora, D. et al. Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. J. Am. Coll. Cardiol. 62, 1267\u20131276, https:\/\/doi.org\/10.1016\/j.jacc.2013.05.073 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"62648_CR47","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.3389\/fimmu.2017.01946","volume":"8","author":"S Mardente","year":"2017","unstructured":"Mardente, S. et al. From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1\/Receptor for Advanced Glycation End Products Axis. Front. Immunol. 8, 1946, https:\/\/doi.org\/10.3389\/fimmu.2017.01946 (2017).","journal-title":"Front. Immunol."},{"key":"62648_CR48","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/bcp.12335","volume":"78","author":"CN Floyd","year":"2014","unstructured":"Floyd, C. N. et al. Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. Br. J. Clin. Pharmacol. 78, 320\u2013328, https:\/\/doi.org\/10.1111\/bcp.12335 (2014).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"62648_CR49","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1158\/2159-8290.CD-12-0216","volume":"2","author":"HS Kuznetsov","year":"2012","unstructured":"Kuznetsov, H. S. et al. Identification of luminal breast cancers that establish a tumor-supportive macroenvironment defined by proangiogenic platelets and bone marrow-derived cells. Cancer Discov. 2, 1150\u20131165, https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0216 (2012).","journal-title":"Cancer Discov."},{"key":"62648_CR50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10585-015-9722-5","volume":"32","author":"JH Pang","year":"2015","unstructured":"Pang, J. H., Coupland, L. A., Freeman, C., Chong, B. H. & Parish, C. R. Activation of tumour cell ECM degradation by thrombin-activated platelet membranes: potentially a P-selectin and GPIIb\/IIIa-dependent process. Clin. Exp. Metastasis 32, 495\u2013505, https:\/\/doi.org\/10.1007\/s10585-015-9722-5 (2015).","journal-title":"Clin. Exp. Metastasis"},{"key":"62648_CR51","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1182\/blood-2011-02-334524","volume":"118","author":"EM Battinelli","year":"2011","unstructured":"Battinelli, E. M., Markens, B. A. & Italiano, J. E. Jr. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood 118, 1359\u20131369, https:\/\/doi.org\/10.1182\/blood-2011-02-334524 (2011).","journal-title":"Blood"},{"key":"62648_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0631-x","volume":"16","author":"D Delgado-Bellido","year":"2017","unstructured":"Delgado-Bellido, D., Serrano-Saenz, S., Fernandez-Cortes, M. & Oliver, F. J. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol. Cancer 16, 65, https:\/\/doi.org\/10.1186\/s12943-017-0631-x (2017).","journal-title":"Mol. Cancer"},{"key":"62648_CR53","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle, M., Begum, S. & Hynes, R. O. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20, 576\u2013590, https:\/\/doi.org\/10.1016\/j.ccr.2011.09.009 (2011).","journal-title":"Cancer Cell"},{"key":"62648_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1073\/pnas.61.1.46","volume":"61","author":"GJ Gasic","year":"1968","unstructured":"Gasic, G. J., Gasic, T. B. & Stewart, C. C. Antimetastatic effects associated with platelet reduction. Proc. Natl Acad. Sci. USA 61, 46\u201352 (1968).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62648_CR55","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/labinvest.2015.49","volume":"95","author":"G Maity","year":"2015","unstructured":"Maity, G. et al. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab. Invest. 95, 702\u2013717, https:\/\/doi.org\/10.1038\/labinvest.2015.49 (2015).","journal-title":"Lab. Invest."},{"key":"62648_CR56","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/carcin\/bgt009","volume":"34","author":"LM Carlson","year":"2013","unstructured":"Carlson, L. M. et al. Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma. Carcinogenesis 34, 1081\u20131088, https:\/\/doi.org\/10.1093\/carcin\/bgt009 (2013).","journal-title":"Carcinogenesis"},{"key":"62648_CR57","doi-asserted-by":"publisher","first-page":"32462","DOI":"10.18632\/oncotarget.8655","volume":"7","author":"P Guillem-Llobat","year":"2016","unstructured":"Guillem-Llobat, P. et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget 7, 32462\u201332477, https:\/\/doi.org\/10.18632\/oncotarget.8655 (2016).","journal-title":"Oncotarget"},{"key":"62648_CR58","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1158\/1940-6207.CAPR-16-0241","volume":"10","author":"LM Lichtenberger","year":"2017","unstructured":"Lichtenberger, L. M. et al. Unlocking Aspirin\u2019s Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1. Cancer Prev. Res. 10, 142\u2013152, https:\/\/doi.org\/10.1158\/1940-6207.CAPR-16-0241 (2017).","journal-title":"Cancer Prev. Res."},{"key":"62648_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-2-19","volume":"2","author":"BK Reuter","year":"2002","unstructured":"Reuter, B. K., Zhang, X. J. & Miller, M. J. Therapeutic utility of aspirin in the ApcMin\/+ murine model of colon carcinogenesis. BMC Cancer 2, 19 (2002).","journal-title":"BMC Cancer"},{"key":"62648_CR60","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall, S. F. et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J. Natl Cancer Inst. 97, 805\u2013812, https:\/\/doi.org\/10.1093\/jnci\/dji140 (2005).","journal-title":"J. Natl Cancer Inst."},{"key":"62648_CR61","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10549-016-4081-8","volume":"161","author":"J Shiao","year":"2017","unstructured":"Shiao, J. et al. Aspirin\/antiplatelet agent use improves disease-free survival and reduces the risk of distant metastases in Stage II and III triple-negative breast cancer patients. Breast Cancer Res. Treat. 161, 463\u2013471, https:\/\/doi.org\/10.1007\/s10549-016-4081-8 (2017).","journal-title":"Breast Cancer Res. Treat."},{"key":"62648_CR62","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/aje\/kwm195","volume":"166","author":"JK Gill","year":"2007","unstructured":"Gill, J. K. et al. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. Am. J. Epidemiol. 166, 1150\u20131158, https:\/\/doi.org\/10.1093\/aje\/kwm195 (2007).","journal-title":"Am. J. Epidemiol."},{"key":"62648_CR63","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1083\/jcb.118.6.1511","volume":"118","author":"MG Lampugnani","year":"1992","unstructured":"Lampugnani, M. G. et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J. Cell Biol. 118, 1511\u20131522 (1992).","journal-title":"J. Cell Biol."},{"key":"62648_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/B978-0-12-394311-8.00006-6","volume":"116","author":"E Dejana","year":"2013","unstructured":"Dejana, E. & Vestweber, D. The role of VE-cadherin in vascular morphogenesis and permeability control. Prog. Mol. Biol. Transl. Sci. 116, 119\u2013144, https:\/\/doi.org\/10.1016\/B978-0-12-394311-8.00006-6 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"62648_CR65","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1073\/pnas.131209798","volume":"98","author":"MJ Hendrix","year":"2001","unstructured":"Hendrix, M. J. et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl Acad. Sci. USA 98, 8018\u20138023, https:\/\/doi.org\/10.1073\/pnas.131209798 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"62648_CR66","doi-asserted-by":"publisher","unstructured":"Lampugnani, M. G., Dejana, E. & Giampietro, C. Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and Vascular Disease. Cold Spring Harb Perspect Biol 10, https:\/\/doi.org\/10.1101\/cshperspect.a029322 (2018).","DOI":"10.1101\/cshperspect.a029322"},{"key":"62648_CR67","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41418-018-0125-4","volume":"26","author":"D Delgado-Bellido","year":"2019","unstructured":"Delgado-Bellido, D. et al. VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression. Cell Death Differ. 26, 348\u2013361, https:\/\/doi.org\/10.1038\/s41418-018-0125-4 (2019).","journal-title":"Cell Death Differ."},{"key":"62648_CR68","doi-asserted-by":"publisher","first-page":"28204","DOI":"10.1074\/jbc.M103083200","volume":"276","author":"H Miyamori","year":"2001","unstructured":"Miyamori, H. et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 276, 28204\u201328211, https:\/\/doi.org\/10.1074\/jbc.M103083200 (2001).","journal-title":"J. Biol. Chem."},{"key":"62648_CR69","doi-asserted-by":"publisher","first-page":"51630","DOI":"10.1074\/jbc.M409214200","volume":"279","author":"TM Williams","year":"2004","unstructured":"Williams, T. M. et al. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2\/9) secretion. J. Biol. Chem. 279, 51630\u201351646, https:\/\/doi.org\/10.1074\/jbc.M409214200 (2004).","journal-title":"J. Biol. Chem."},{"key":"62648_CR70","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2006.08.016","volume":"249","author":"B Sun","year":"2007","unstructured":"Sun, B. et al. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett. 249, 188\u2013197, https:\/\/doi.org\/10.1016\/j.canlet.2006.08.016 (2007).","journal-title":"Cancer Lett."},{"key":"62648_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/23948","volume":"396","author":"MJ Yin","year":"1998","unstructured":"Yin, M. J., Yamamoto, Y. & Gaynor, R. B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396, 77\u201380, https:\/\/doi.org\/10.1038\/23948 (1998).","journal-title":"Nature"},{"key":"62648_CR72","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1159\/000464434","volume":"41","author":"C Shi","year":"2017","unstructured":"Shi, C. et al. Aspirin Inhibits IKK-beta-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator. Cell Physiol. Biochem. 41, 1313\u20131324, https:\/\/doi.org\/10.1159\/000464434 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"62648_CR73","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/sj.onc.1209002","volume":"25","author":"PF Cezar-de-Mello","year":"2006","unstructured":"Cezar-de-Mello, P. F., Nascimento-Silva, V., Villela, C. G. & Fierro, I. M. Aspirin-triggered Lipoxin A4 inhibition of VEGF-induced endothelial cell migration involves actin polymerization and focal adhesion assembly. Oncogene 25, 122\u2013129, https:\/\/doi.org\/10.1038\/sj.onc.1209002 (2006).","journal-title":"Oncogene"},{"key":"62648_CR74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/1-59259-782-3:013","volume":"272","author":"JP Cazenave","year":"2004","unstructured":"Cazenave, J. P. et al. Preparation of washed platelet suspensions from human and rodent blood. Methods Mol. Biol. 272, 13\u201328, https:\/\/doi.org\/10.1385\/1-59259-782-3:013 (2004).","journal-title":"Methods Mol. Biol."},{"key":"62648_CR75","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10456-016-9520-y","volume":"19","author":"LM Ebert","year":"2016","unstructured":"Ebert, L. M. et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis 19, 463\u2013486, https:\/\/doi.org\/10.1007\/s10456-016-9520-y (2016).","journal-title":"Angiogenesis"},{"key":"62648_CR76","doi-asserted-by":"publisher","first-page":"46492","DOI":"10.18632\/oncotarget.10216","volume":"7","author":"LY Tan","year":"2016","unstructured":"Tan, L. Y. et al. Desmoglein 2 promotes vasculogenic mimicry in melanoma and is associated with poor clinical outcome. Oncotarget 7, 46492\u201346508, https:\/\/doi.org\/10.18632\/oncotarget.10216 (2016).","journal-title":"Oncotarget"},{"key":"62648_CR77","first-page":"3591","volume":"9","author":"RF Hennigan","year":"1994","unstructured":"Hennigan, R. F., Hawker, K. L. & Ozanne, B. W. Fos-transformation activates genes associated with invasion. Oncogene 9, 3591\u20133600 (1994).","journal-title":"Oncogene"},{"key":"62648_CR78","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/jth.13397","volume":"14","author":"M Lebois","year":"2016","unstructured":"Lebois, M. et al. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. J. Thromb. Haemost. 14, 1882\u20131887, https:\/\/doi.org\/10.1111\/jth.13397 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"62648_CR79","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","volume":"22","author":"S Reagan-Shaw","year":"2008","unstructured":"Reagan-Shaw, S., Nihal, M. & Ahmad, N. Dose translation from animal to human studies revisited. FASEB J. 22, 659\u2013661, https:\/\/doi.org\/10.1096\/fj.07-9574LSF (2008).","journal-title":"FASEB J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62648-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62648-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T04:24:20Z","timestamp":1670300660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62648-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,3]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62648"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62648-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737680816.793573817","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,3]]},"assertion":[{"value":"4 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5869"}}